Desensitization, Immunologic

14 trials

Sponsors

Takase Takafumi, National Biopreparations Center (BIOCEN), National Center of Bioproducts (BIOCEN), National Center of Bioproducts (BioCen), National Center of Bioproducts (BioCen)

Conditions

AsthmaAsthma.Bronchial asthmaBronchial asthma.Food allergy (milk) Food allergy, milk allergy, anaphylaxis

Phase 2

Efficacy of VALERGEN-DP subcutaneous vaccine in asthmatic adults

Active, not recruitingRPCEC00000027

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2003-03-17Updated: 2026-03-30

Efficacy of VALERGENT-BT subcutaneous vaccine in asthmatic adults

Active, not recruitingRPCEC00000026

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2003-03-16Updated: 2026-03-30

Efficacy of VALERGEN-BT sublingual vaccine in asthmatic adults.

Active, not recruitingRPCEC00000029

National Biopreparations Center (BIOCEN)Asthma

Start: 2005-09-07Updated: 2026-03-30

Efficacy of VALERGEN-DS sublingual vaccine in asthmatic adults

Active, not recruitingRPCEC00000030

National Biopreparations Center (BIOCEN)Bronchial asthma.

Start: 2005-09-07Updated: 2026-03-30

Evidence of the clinical efficacy of VALERGEN-DP vaccine in asthmatics

Active, not recruitingRPCEC00000037

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2006-05-10Updated: 2026-03-30

Evidence of the clinical efficacy of VALERGEN-DS vaccine in asthmatics.

Active, not recruitingRPCEC00000032

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2006-05-10Updated: 2026-03-30

Efficacy of VALERGEN-DP sublingual vaccine in asthmatic adults.

Active, not recruitingRPCEC00000034

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2005-09-07Updated: 2026-03-30

Evidence of the clinical efficacy of VALERGEN-BT vaccine in asthmatics

Active, not recruitingRPCEC00000033

National Biopreparations Center (BIOCEN)Bronchial asthma.

Start: 2006-05-10Updated: 2026-03-30

Combined sublingual immunotherapy VALERGEN-DP and VALERGEN-BT-Asthma-Adults-Phase II

RecruitingRPCEC00000240

National Center of Bioproducts (BIOCEN)Asthma

Start: 2019-02-07Target: 120Updated: 2026-03-30

Subcutaneous immunotherapy with PROLINEM-DS-Asthma- Adults-Fase II

RecruitingRPCEC00000278

National Center of Bioproducts (BioCen)Asthma

Start: 2019-04-30Target: 60Updated: 2026-03-30

VALERGEN-combination of routes- Asthma-Adults-Phase II

Active, not recruitingRPCEC00000298

National Center of Bioproducts (BioCen)Asthma

Start: 2020-07-01Target: 180Updated: 2026-03-30

Epicutaneous Immunotherapy for Milk Allergy

Active, not recruitingJPRN-jRCTs041200024

Takase TakafumiFood allergy (milk) Food allergy, milk allergy, anaphylaxis

Start: 2020-12-09Target: 40Updated: 2025-07-18

Phase 3

Efficacy of VALERGEN-DS subcutaneous vaccine in asthmatic adults.

Active, not recruitingRPCEC00000028

National Biopreparations Center (BIOCEN)Bronchial asthma

Start: 2003-03-16Updated: 2026-03-30

Phase 4

Pharmacovigilance-VALERGEN-Asthma

Active, not recruitingRPCEC00000231

National Center of Bioproducts (BIOCEN)Asthma.

Start: 2011-02-01Target: 2108Updated: 2026-03-30

Related Papers

Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized <i>Blomia tropicalis</i> vaccine.

2020-04-109 citations